Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 841, Suchdauer: 0.88s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Real-world clinical utility of tumor whole-genome sequencing in solid cancers

von van Putten, Jeffrey ; Snaebjornsson, Petur ; Bosch, Linda J. W. ; et al.

Nature Medicine. 32(4):1286-1295
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

2
Author Correction: Real-world clinical utility of tumor whole-genome sequencing in solid cancers

von van Putten, Jeffrey ; Snaebjornsson, Petur ; Bosch, Linda J. W. ; et al.

Nature Medicine. 32(4):1555-1555
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

3
Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases

von Wessels, Peter H. ; Cornelissen, Sten ; Monkhorst, Kim ; et al.

In The Breast February 2026 85
- View full text via DOI
Merkliste

4
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 study

von Douma, Li-Anne H ; van der Noort, Vincent ; Lalezari, Ferry ; et al.

In The Lancet Oncology December 2025 26(12):1676-1684
- View full text via DOI
Merkliste

5
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid

von van Linder, Berit M.H. ; Brandsma, Dieta ; Verhoeven, Els ; et al.

In European Journal of Cancer 16 October 2025 229
- View full text via DOI
Merkliste

6
Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment

von J.W. Tijmen van der Wel, MD ; Merel Jebbink, MD ; Vincent van der Noort, PhD ; et al.

JTO Clinical and Research Reports, Vol 6, Iss 9, Pp 100853- (2025)

Schlagworte: EGFR; NSCLC; Osimertinib; Resistance; ctDNA; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

7
The DETECTION project part 1: An international Delphi survey about diagnostics and treatment of anterior mediastinal cystic lesions

von Marcuse, Florit ; Dumoulin, Daphne ; Hartemink, Koen ; et al.

In Lung Cancer January 2025 199
- View full text via DOI
Merkliste

8
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

von Milou M F Schuurbiers ; Christopher G Smith ; Koen J Hartemink ; et al.

PLoS Medicine, Vol 22, Iss 4, p e1004574 (2025)

Schlagworte: Medicine
- View full text via DOI
Merkliste

9
Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer

von Franziska Böttger ; Teodora Radonic ; Idris Bahce ; et al.

Molecular Oncology, Vol 18, Iss 6, Pp 1417-1436 (2024)

Schlagworte: adjuvant chemotherapy; biomarker; lung cancer; mass‐spectrometry; platinum; proteomics; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

10
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice

von Samsom, Kris G. ; Bosch, Linda J. W. ; Schipper, Luuk J. ; et al.

Nature Protocols: Recipes for Researchers. 19(3):700-726
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

11
ROS1 fusions in resected stage I-III adenocarcinoma: Results from the European Thoracic Oncology Platform Lungscape project

von Speel, Ernst-Jan M. ; Dafni, Urania ; Thunnissen, Erik ; et al.

In Lung Cancer August 2024 194
- View full text via DOI
Merkliste

12
External validation of a serum tumor marker algorithm for early prediction of no durable benefit to immunotherapy in metastastic non-small cell lung carcinoma

von Milou M. F. Schuurbiers ; Freek A. van Delft ; Hendrik Koffijberg ; et al.

Tumor Biology, Vol 47 (2025)

Schlagworte: Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

13
Longitudinal Circulating Tumor DNA–Guided Resistance Analysis During Second-Line Osimertinib Treatment

von van der Wel,J. W.Tijmen ; Jebbink,Merel ; van der Noort,Vincent ; et al.

Schlagworte: ctDNA; EGFR; NSCLC; Osimertinib; Resistance; Oncology; Pulmonary and Respiratory Medicine
- View full text via BASE
Merkliste

14
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics

von Koster, Roelof ; Schipper, Luuk J. ; Giesbertz, Noor A.A. ; et al.

In Genetics in Medicine February 2024 26(2)
- View full text via DOI
Merkliste

15
Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products

von Suzanne M. Castenmiller ; Nandhini Kanagasabesan ; Aurélie Guislain ; et al.

OncoImmunology, Vol 13, Iss 1 (2024)

Schlagworte: Immune infiltrate; NSCLC; TIL therapy; TLS formation; Immunologic diseases. Allergy; RC581-607; Neoplasms. Tumors. Oncology. Including cancer and carcinogens; RC254-282
- View full text via DOI
Merkliste

16
Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors:Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol

von Verkerk,Karlijn ; Haj Mohammad,Soemeya F ; Zeverijn,Laurien J ; et al.

Schlagworte: Taverne; Journal Article
- View full text via BASE
Merkliste

17
Dieses Ergebnis aus Science Citation Index Expanded kann Gästen nicht angezeigt werden.
Login für vollen Zugriff.
- Zur Referenz in Web of Science
Merkliste

18
Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent:A retrospective validation study

von Schuurbiers,Milou M.F. ; Smith,Christopher G. ; Hartemink,Koen J. ; et al.

Schlagworte: Humans; Carcinoma; Non-Small-Cell Lung/genetics; Circulating Tumor DNA/blood; Lung Neoplasms/genetics; Male; Female; Neoplasm Recurrence; Local/genetics; Aged; Middle Aged; Retrospective Studies; Neoplasm Staging; Biomarkers; Tumor/blood; 80 and over; Adult; Reproducibility of Results; Predictive Value of Tests; General Medicine; Journal Article; Validation Studies
- View full text via BASE
Merkliste

19
Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma:Results From the European Thoracic Platform Mesoscape Project

von Haberecker, Martina ; Rüschoff, Jan H. ; Andriakopoulou, Charitini ; et al.

Haberecker, M, Rüschoff, J H, ETOP Mesoscape ConsortiumEuropean Thoracic Oncology Platform (ETOP) Mesoscape Contributors, Andriakopoulou, C, Gray, S G, Nackaerts, K, De Perrot, M, Brcic, L, Nadal, E, Tsimpoukis, S, Ampollini, L, Aerts, J G, Kirschner, M B, Monkhorst, K, Weynand, B, Bavaghar-Zaeimi, F, Samarzija, M, Llatjos, R, Finn, S P, Silini, E, Von Der Thüsen, J, Vagenknecht, P, Tsourti, Z, Kerr, K M, Kammler, R, Peters, S, Baas, P, Opitz, I, Stahel, R & Curioni-Fontecedro, A 2025, 'Prevalence and Clinical Association of CD276 (B7-H3) Expression in Pleural Mesothelioma : Results From the European Thoracic Platform Mesoscape Project', JCO ....

Schlagworte: /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being; name=SDG 3 - Good Health and Well-being
- View full text via BASE
Merkliste

20
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 study

von Douma, Li-Anne H ; Lalezari, Ferry ; van der Noort, Vincent ; et al.

In The Lancet Oncology November 2023 24(11):1219-1228
- View full text via DOI
Merkliste

21
European Epidemiology of Pleural Mesothelioma—Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database

von Stahel, Rolf ; Hiltbrunner, Anita ; Kammler, Rosita ; et al.

In Journal of Thoracic Oncology September 2023 18(9):1233-1247
- View full text via DOI
Merkliste

22
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers

von van Kooten, Job P. ; de Gooijer, Cornedine J. ; von der Thüsen, Jan H. ; et al.

In European Journal of Surgical Oncology March 2023 49(3):611-618
- View full text via DOI
Merkliste

23
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

von Rüschoff, Jan Hendrik ; Haberecker, Martina ; Tsourti, Zoi ; et al.

In Modern Pathology December 2022 35(12):1888-1899
- View full text via DOI
Merkliste

24
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF?

von Wessels, Peter H. ; Boelens, Mirjam C. ; Monkhorst, Kim ; et al.

Journal of Neuro-Oncology. 162(1):1-13
- Zum Volltext (via ReDI)
Merkliste

25
Challenges in breast cancer genetic testing. A call for novel forms of multidisciplinary care and long-term evaluation

von Menko, Fred H. ; Monkhorst, Kim ; Hogervorst, Frans B.L. ; et al.

In Critical Reviews in Oncology / Hematology August 2022 176
- View full text via DOI
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag